G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Revenue

In the year 2025, G&E Herbal Biotechnology had annual revenue of 309.13M TWD with 24.13% growth. G&E Herbal Biotechnology had revenue of 69.17M in the quarter ending December 31, 2025, a decrease of -3.69%.

• Revenue: 309.13M
• Revenue Growth: +24.13%
• P/S Ratio: 7.70
• Revenue / Employee: 7.93M
• Employees: 39
• Market Cap: 2.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	309.13M	60.10M	24.13%
Dec 31, 2024	249.03M	67.59M	37.25%
Dec 31, 2023	181.44M	116.84M	180.84%
Dec 31, 2022	64.61M	40.04M	162.94%
Dec 31, 2021	24.57M	-3.66M	-12.96%